LAKEYN SMITH: Open Payments
NPI 1467115600 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 11 payments from 8 companies in 2025. Trend: 2023 $759 · 2024 $409 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 2 | $104 |
| Insulet Corporation | 1 | $80 |
| Exact Sciences Corporation | 3 | $52 |
| Alkermes, Inc. | 1 | $30 |
| Dexcom, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: QULIPTA, Auvelity, Omnipod, The Cologuard Plus Collection Kit, VIVITROL, Dexcom G6 Transmitter, Kerendia, JARDIANCE.
Industry payments across LA — which companies pay providers there.
